Table 1. Patients’ Characteristics.
| Characteristic (n = 34) | |
|---|---|
| Age (years), median (range) | 71 (57 - 87) |
| Male sex, n (%) | 28 (82) |
| ECOG-PS score, n (%) | |
| 0 | 20 (59) |
| ≥ 1 | 14 (41) |
| Primary tumor site, n (%) | |
| Bladder | 13 (38) |
| Upper urinary tract | 12 (35) |
| Bladder + upper urinary tract | 9 (27) |
| Pure UC in histologic testing, n (%) | 27 (79) |
| Number of prior chemotherapy regimens | |
| 1 | 22 (64) |
| 2 | 6 (18) |
| 3 | 6 (18) |
| Hb < 10g/dL, n (%) | 14 (41) |
| NLR, median (range) | 2.2 (0.7 - 18.0) |
| Albumin < 4.1 g/dL, n (%) | 23 (68) |
| LDH > 222 U/L, n (%) | 10 (29) |
| CRP > 0.14 mg/dL, n (%) | 26 (76) |
| Visceral metastases, n (%) | 27 (79) |
| Liver metastases, n (%) | 11 (32) |
| Time from previous chemotherapy < 3 months, n (%) | 27 (79) |
ECOG-PS: Eastern Cooperative Oncology Group Performance Status; UC: urothelial carcinoma; Hb: hemoglobin; NLR: neutrophil/lymphocyte ratio; LDH: lactate dehydrogenase; CRP: C-reactive protein.